Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A D Hamilton

Showing results (21-30 of 85) with videos related to

Pageof 9
Sort By:
Bioorganic & Medicinal Chemistry|August 1, 1997
Design, synthesis and evaluation of synthetic receptors for the recognition of aspartate pairs in an alpha-helical conformationJ S Albert, M W Peczuh, A D Hamilton
Journal of the American Chemical Society|July 18, 2001
Toward proteomimetics: terphenyl derivatives as structural and functional mimics of extended regions of an alpha-helixB P Orner, J T Ernst, A D Hamilton
Anti-Cancer Drug Design|June 1, 1997
Inhibition of Ras prenylation: a signaling target for novel anti-cancer drug designE C Lerner, A D Hamilton, S M Sebti
Diabetic Medicine : a Journal of the British Diabetic Association|July 1, 1989
The introduction of a quality assessment scheme for extra-laboratory blood glucose analysisA D Hamilton, K R Allen, A K Waters
Cancer Research|October 1, 1995
Ras CAAX peptidomimetic FTI 276 selectively blocks tumor growth in nude mice of a human lung carcinoma with K-Ras mutation and p53 deletionJ Sun, Y Qian, A D Hamilton, et al.
Oncogene|April 3, 1998
Both farnesyltransferase and geranylgeranyltransferase I inhibitors are required for inhibition of oncogenic K-Ras prenylation but each alone is sufficient to suppress human tumor growth in nude mouse xenograftsJ Sun, Y Qian, A D Hamilton, et al.
Journal of Medicinal Chemistry|January 5, 1996
Design and synthesis of non-peptide Ras CAAX mimetics as potent farnesyltransferase inhibitorsY Qian, A Vogt, S M Sebti, et al.
The Journal of Biological Chemistry|November 10, 1995
Disruption of oncogenic K-Ras4B processing and signaling by a potent geranylgeranyltransferase I inhibitorE C Lerner, Y Qian, A D Hamilton, et al.
Journal of Clinical & Laboratory Immunology|July 1, 1986
Synthesis of complement components (C3, C2, B and C1-inhibitor) and lysozyme by human monocytes and macrophagesD Lappin, A D Hamilton, L Morrison, et al.
Annals of Clinical Biochemistry|July 1, 1992
Prevalence of haemoglobin variants in a diabetic population and their effect on glycated haemoglobin measurementK R Allen, A D Hamilton, H J Bodansky, et al.
Pageof 9

Showing results (21-30 of 85) with videos related to

Sort By:
Pageof 9
Bioorganic & Medicinal Chemistry|August 1, 1997
Design, synthesis and evaluation of synthetic receptors for the recognition of aspartate pairs in an alpha-helical conformationJ S Albert, M W Peczuh, A D Hamilton
Journal of the American Chemical Society|July 18, 2001
Toward proteomimetics: terphenyl derivatives as structural and functional mimics of extended regions of an alpha-helixB P Orner, J T Ernst, A D Hamilton
Anti-Cancer Drug Design|June 1, 1997
Inhibition of Ras prenylation: a signaling target for novel anti-cancer drug designE C Lerner, A D Hamilton, S M Sebti
Diabetic Medicine : a Journal of the British Diabetic Association|July 1, 1989
The introduction of a quality assessment scheme for extra-laboratory blood glucose analysisA D Hamilton, K R Allen, A K Waters
Cancer Research|October 1, 1995
Ras CAAX peptidomimetic FTI 276 selectively blocks tumor growth in nude mice of a human lung carcinoma with K-Ras mutation and p53 deletionJ Sun, Y Qian, A D Hamilton, et al.
Oncogene|April 3, 1998
Both farnesyltransferase and geranylgeranyltransferase I inhibitors are required for inhibition of oncogenic K-Ras prenylation but each alone is sufficient to suppress human tumor growth in nude mouse xenograftsJ Sun, Y Qian, A D Hamilton, et al.
Journal of Medicinal Chemistry|January 5, 1996
Design and synthesis of non-peptide Ras CAAX mimetics as potent farnesyltransferase inhibitorsY Qian, A Vogt, S M Sebti, et al.
The Journal of Biological Chemistry|November 10, 1995
Disruption of oncogenic K-Ras4B processing and signaling by a potent geranylgeranyltransferase I inhibitorE C Lerner, Y Qian, A D Hamilton, et al.
Journal of Clinical & Laboratory Immunology|July 1, 1986
Synthesis of complement components (C3, C2, B and C1-inhibitor) and lysozyme by human monocytes and macrophagesD Lappin, A D Hamilton, L Morrison, et al.
Annals of Clinical Biochemistry|July 1, 1992
Prevalence of haemoglobin variants in a diabetic population and their effect on glycated haemoglobin measurementK R Allen, A D Hamilton, H J Bodansky, et al.
Pageof 9